Condition
ITP clinical trials and research
As of November 12, 2026, Find a Trial lists 2 ITP clinical trials that are recruiting, at sites in 13 countries (most in Serbia (2), Spain (2), Bulgaria (1)). By phase: Phase 1/2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 13Countries
All recruiting trials (2)
-
Efgartigimod IV for adolescents (12–17) with chronic immune thrombocytopenia
This trial will try intravenous efgartigimod to see if it safely raises platelet counts in people aged 12 to 17 with chronic ITP.
-
Budoprutug for adults with immune thrombocytopenia (ITP)
This trial will test whether two IV doses of budoprutug are safe and can help raise platelet counts in adults with ITP who still have platelets under 30,000/µL after prior treatment.
Related topics
Quick answers
How many ITP clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in Serbia (2 trials), Spain (2 trials), Bulgaria (1 trial), Greece (1 trial), Ukraine (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.